Locally produced antihemophilic B agents are safe, KGC says

Published: 2002-09-18 06:56:00

Updated: 2002-09-18 06:56:00

In line with the recent report that some hemophiliacs in Korea are infected with AIDS during the administration of locally produced antihemophilic B agents, Korea Green Cross (KGC) has argued that this report is beyond the rationale, citing that an investigation team organized in the early 1990s ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK